These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 3518846)

  • 1. A comparative review of the Hammersmith (1971-75) and Edinburgh (1977-82) neutron therapy trials of certain cancers of the oral cavity, oropharynx, larynx and hypopharynx. Medical Research Council Neutron Therapy Working Group.
    Br J Radiol; 1986 May; 59(701):429-40. PubMed ID: 3518846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of radiation therapy oncology group protocol 83-13.
    Cox JD; Pajak TF; Marcial VA; Hanks GE; Mohiuddin M; Fu KK; Byhardt RW; Rubin P
    Int J Radiat Oncol Biol Phys; 1990 Mar; 18(3):515-21. PubMed ID: 2180866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First results of a randomized clinical trial of fast neutrons compared with X or gamma rays in treatment of advanced tumours of the head and neck. Report to the Medical Research Council.
    Catterall M; Sutherland I; Bewley DK
    Br Med J; 1975 Jun; 2(5972):653-6. PubMed ID: 1095114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.
    Rosenthal DI; Mohamed ASR; Garden AS; Morrison WH; El-Naggar AK; Kamal M; Weber RS; Fuller CD; Peters LJ
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1002-1011. PubMed ID: 28721881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered and conventional fractionated radiotherapy in locoregional control and survival of patients with squamous cell carcinoma of the larynx, oropharynx, and hypopharynx.
    Krstevska V; Crvenkova S
    Croat Med J; 2006 Feb; 47(1):42-52. PubMed ID: 16489696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of fast neutron therapy for advanced carcinomas of the oral cavity and oropharynx.
    Skołyszewski J; Reinfuss M
    Radiobiol Radiother (Berl); 1985; 26(1):85-9. PubMed ID: 4001344
    [No Abstract]   [Full Text] [Related]  

  • 8. Fast neutron treatment for squamous cell carcinoma of the head and neck: final report of Edinburgh randomised trial.
    MacDougall RH; Orr JA; Kerr GR; Duncan W
    BMJ; 1990 Dec; 301(6763):1241-2. PubMed ID: 2125513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast neutron teletherapy for advanced carcinoma of hypopharynx and supraglottic larynx.
    Laramore GE; Johnson J; Griffin TW; Tong D; Groudine MT; Kurtz JM; Russell AH; Parker RG
    Acta Radiol Oncol; 1980; 19(6):439-47. PubMed ID: 6263057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of radiation therapy in addition to surgery for cancer of the head and neck.
    Sadeghi A; McLaren J; Grist WL; Tran L; Kuisk H
    Otolaryngol Head Neck Surg; 1986 Jun; 94(5):601-4. PubMed ID: 3088523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The early response of oral, oropharyngeal, hypopharyngeal and laryngeal cancer related to local control and survival.
    Dawes PJ
    Br J Cancer Suppl; 1980 Apr; 4():14-6. PubMed ID: 6932917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment experience with 15 MeV fast neutrons in the oral cavity and oropharynx.
    Herskovic A; Cox EB; Fender F; Schell M; Henshaw W; Rogers C; Ornitz R
    Cancer; 1984 May; 53(10):2087-90. PubMed ID: 6423262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study.
    Sanguineti G; Richetti A; Bignardi M; Corvo' R; Gabriele P; Sormani MP; Antognoni P
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):762-71. PubMed ID: 15708255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients.
    Suwinski R; Sowa A; Rutkowski T; Wydmanski J; Tarnawski R; Maciejewski B
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):399-412. PubMed ID: 12738315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
    Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
    Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for local-regional recurrence following preoperative radiation therapy and surgery for head and neck cancer (stage II-IVB).
    Shikama N; Sasaki S; Nishikawa A; Koiwai K; Yoshino F; Hirase Y; Kawakami R; Kadoya M; Oguchi M
    Radiology; 2003 Sep; 228(3):789-94. PubMed ID: 12954897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate and radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, oropharynx, supraglottic larynx, and hypopharynx. (Preliminary report of a controlled clinical trial of the Radiation Therapy Oncology Group).
    Kramer S
    Can J Otolaryngol; 1975; 4(2):213-8. PubMed ID: 1139418
    [No Abstract]   [Full Text] [Related]  

  • 18. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radical radiotherapy for squamous cell carcinoma of the larynx, oropharynx and hypopharynx: patterns of recurrence, treatment and survival.
    Jones AS; Husband D; Rowley H
    Clin Otolaryngol Allied Sci; 1998 Dec; 23(6):496-511. PubMed ID: 9884802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
    Garden AS; Morrison WH; Ang KK; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.